Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Hospira, Inc.    HSP

 SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensus 
Company
Hospira, Inc. provides injectable drugs and infusion technologies.Its offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services.The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL.  
Sector
Pharmaceuticals
Calendar
02/15Earnings Release
More about the company
Latest news on HOSPIRA, INC.
2015 HOSPIRA : Announces First Installation of Plum 360™ Infusion System With H..
2015 HOSPIRA : Announces First Installation of Plum 360(TM) Infusion System With Hosp..
2015DJPFIZER : Buy of Hospira Gets Green Light
2015DJPFIZER : Gets U.S. Approval to Acquire Hospira, With Divestitures
2015 HOSPIRA : Expert committee BACKS Hospira’s InflectraTM
2015 HOSPIRA : Charleston Area Medical Center Integrates Smart Pump Technology to Adv..
2015 HOSPIRA : TGA Approves First mAb Biosimilar
2015 HOSPIRA : Applauds UK's NICE for Issuing Adoption Resource to Help Drive the Int..
2015DJPFIZER : Gets EU Green Light for Hospira Merger
2015 HOSPIRA : Pfizer wins EU approval for $15 billion Hospira buy
More news
Sector news : Generic Pharmaceuticals
12/03DJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
12/02DJJOHNSON & JOHNSON : Jury Orders Johnson & Johnson to Pay More Than $1 Billion in..
12/01DJValeant Deal Talks Collapse Over Price -- WSJ
12/01DJCSL : Eyes Biggest Undertaking Yet in Heart Therapy Trial
More sector news : Generic Pharmaceuticals
4-Traders Strategies on HOSPIRA, INC. 
2013End of the technical recovery
More Strategies
News from SeekingAlpha
10/05 ABBOTT : Current Uncertainties Offer A Buying Opportunity
04/19 New Management At ICU Medical Has Produced Positive Results
03/21 PFIZER : 30%+ Discount With 4% Yield
2015 PREMARKET BIOTECH DIGEST : Trouble For Anticoagulants, Gilead U.S. Hep C Sales
2015 Hospira Acquisition To Add Shareholder Value For Pfizer
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
F. Michael Ball Chief Executive Officer & Director
John C. Staley Non-Executive Chairman
Matthew R. Stober Senior Vice President-Operations
Thomas E. Werner Chief Financial Officer & Senior Vice President
Sumant Ramachandra Chief Scientific Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
HOSPIRA, INC.0.00%0
SUN PHARMACEUTICAL IND..-11.92%25 404
OTSUKA HOLDINGS CO LTD4.22%22 196
ONO PHARMACEUTICAL CO...-42.00%13 002
ASPEN PHARMACARE HOLDI..-8.64%9 268
SHANGHAI FOSUN PHARMAC..-1.83%7 929
More Results